Search results
Earnings call: Imunon reports on Q1 2024, optimistic about cancer treatment By Investing.com
Investing.com· 2 hours agoImunon (ticker: IMNN) has announced its financial results and progress in clinical trials for the...
Why Newsom’s allies in health care are slamming his budget
Politico· 2 hours agoIt now heads back to the Senate for a final vote before landing...funding that we need to support testing and disease investigators, we potentially end up in a situation that’s very much like ...
Five babies die of whooping cough as cases rise across UK
The Independent via Yahoo News· 16 hours agoHe said the figures from the UKHSA highlighted the need for “rapid action” to prevent a further fall...
American Express Stock Still Looks Attractive Despite Soaring 29% This Year
Motley Fool via Yahoo Finance· 14 hours agoThe company has increased its dividend at rates between 17% and 21% each year since 2022. Further,...
Chief medical officer denies straying into political issues during pandemic
Press Association News via AOL· 3 days agoA full transcript of today’s hearing will be available on the website shortly with an accessible...
Owners plan to close downtown Belleville bar after 20 years and sell building with patio
Belleville News-Democrat· 15 hours agoA popular bar in downtown Belleville has been listed for sale for 10 years, but the owners say they weren’t really motivated to leave a place they loved or reduce the price. It’s different now ...
Closed (a.k.a. zombie) colleges are rising from the dead online | The Excerpt
USA TODAY via Yahoo News· 4 days agoPresident Joe Biden vows to withhold weapons from Israel if its forces make a major Rafah invasion. There's a new COVID-19 variant called FLiRT. USA < ...
Five years in, more than 100,000 Arkansans sign up for medical cannabis
Alabama Reflector via Yahoo News· 5 hours agoThis story originally appeared on Arkansas Advocate. Since the launch of medical marijuana in...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 5 days agoBut the science of DNA-based drugs was on the experimental fringe of the biopharma landscape. Not...
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
WRBL Columbus· 5 hours agoINOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases ...